nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.131	0.191	CbGbCtD
Alprazolam—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0874	0.127	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0874	0.127	CbGbCtD
Alprazolam—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0676	0.0982	CbGbCtD
Alprazolam—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0655	0.0952	CbGbCtD
Alprazolam—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0512	0.0744	CbGbCtD
Alprazolam—CYP2C9—Dexamethasone—ankylosing spondylitis	0.044	0.0639	CbGbCtD
Alprazolam—CYP3A4—Betamethasone—ankylosing spondylitis	0.0439	0.0638	CbGbCtD
Alprazolam—CYP3A4—Prednisolone—ankylosing spondylitis	0.0434	0.063	CbGbCtD
Alprazolam—CYP3A4—Prednisone—ankylosing spondylitis	0.0409	0.0595	CbGbCtD
Alprazolam—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0256	0.0371	CbGbCtD
Alprazolam—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000584	0.00187	CcSEcCtD
Alprazolam—Infestation—Methotrexate—ankylosing spondylitis	0.000584	0.00187	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000583	0.00187	CcSEcCtD
Alprazolam—Depression—Methotrexate—ankylosing spondylitis	0.000582	0.00187	CcSEcCtD
Alprazolam—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000582	0.00187	CcSEcCtD
Alprazolam—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000582	0.00187	CcSEcCtD
Alprazolam—Discomfort—Triamcinolone—ankylosing spondylitis	0.000581	0.00187	CcSEcCtD
Alprazolam—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00058	0.00186	CcSEcCtD
Alprazolam—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000579	0.00186	CcSEcCtD
Alprazolam—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000576	0.00185	CcSEcCtD
Alprazolam—Angioedema—Dexamethasone—ankylosing spondylitis	0.000573	0.00184	CcSEcCtD
Alprazolam—Angioedema—Betamethasone—ankylosing spondylitis	0.000573	0.00184	CcSEcCtD
Alprazolam—Angiopathy—Prednisone—ankylosing spondylitis	0.000569	0.00183	CcSEcCtD
Alprazolam—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000568	0.00182	CcSEcCtD
Alprazolam—Malaise—Dexamethasone—ankylosing spondylitis	0.000566	0.00181	CcSEcCtD
Alprazolam—Malaise—Betamethasone—ankylosing spondylitis	0.000566	0.00181	CcSEcCtD
Alprazolam—Oedema—Triamcinolone—ankylosing spondylitis	0.000564	0.00181	CcSEcCtD
Alprazolam—Vertigo—Dexamethasone—ankylosing spondylitis	0.000563	0.00181	CcSEcCtD
Alprazolam—Vertigo—Betamethasone—ankylosing spondylitis	0.000563	0.00181	CcSEcCtD
Alprazolam—Syncope—Betamethasone—ankylosing spondylitis	0.000562	0.0018	CcSEcCtD
Alprazolam—Syncope—Dexamethasone—ankylosing spondylitis	0.000562	0.0018	CcSEcCtD
Alprazolam—Infection—Triamcinolone—ankylosing spondylitis	0.00056	0.0018	CcSEcCtD
Alprazolam—Sweating—Methotrexate—ankylosing spondylitis	0.00056	0.0018	CcSEcCtD
Alprazolam—Infection—Methylprednisolone—ankylosing spondylitis	0.000559	0.00179	CcSEcCtD
Alprazolam—Shock—Triamcinolone—ankylosing spondylitis	0.000555	0.00178	CcSEcCtD
Alprazolam—Insomnia—Prednisolone—ankylosing spondylitis	0.000555	0.00178	CcSEcCtD
Alprazolam—Shock—Methylprednisolone—ankylosing spondylitis	0.000554	0.00178	CcSEcCtD
Alprazolam—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000552	0.00177	CcSEcCtD
Alprazolam—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000552	0.00177	CcSEcCtD
Alprazolam—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000551	0.00177	CcSEcCtD
Alprazolam—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000551	0.00177	CcSEcCtD
Alprazolam—Epistaxis—Methotrexate—ankylosing spondylitis	0.000551	0.00177	CcSEcCtD
Alprazolam—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000551	0.00177	CcSEcCtD
Alprazolam—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000551	0.00177	CcSEcCtD
Alprazolam—Mental disorder—Prednisone—ankylosing spondylitis	0.00055	0.00176	CcSEcCtD
Alprazolam—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000549	0.00176	CcSEcCtD
Alprazolam—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000547	0.00175	CcSEcCtD
Alprazolam—Malnutrition—Prednisone—ankylosing spondylitis	0.000546	0.00175	CcSEcCtD
Alprazolam—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000545	0.00175	CcSEcCtD
Alprazolam—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000544	0.00175	CcSEcCtD
Alprazolam—Convulsion—Betamethasone—ankylosing spondylitis	0.000543	0.00174	CcSEcCtD
Alprazolam—Convulsion—Dexamethasone—ankylosing spondylitis	0.000543	0.00174	CcSEcCtD
Alprazolam—Myalgia—Dexamethasone—ankylosing spondylitis	0.000534	0.00171	CcSEcCtD
Alprazolam—Myalgia—Betamethasone—ankylosing spondylitis	0.000534	0.00171	CcSEcCtD
Alprazolam—Anxiety—Dexamethasone—ankylosing spondylitis	0.000532	0.00171	CcSEcCtD
Alprazolam—Anxiety—Betamethasone—ankylosing spondylitis	0.000532	0.00171	CcSEcCtD
Alprazolam—Discomfort—Dexamethasone—ankylosing spondylitis	0.000528	0.00169	CcSEcCtD
Alprazolam—Discomfort—Betamethasone—ankylosing spondylitis	0.000528	0.00169	CcSEcCtD
Alprazolam—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000526	0.00169	CcSEcCtD
Alprazolam—Hepatitis—Methotrexate—ankylosing spondylitis	0.000524	0.00168	CcSEcCtD
Alprazolam—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000518	0.00166	CcSEcCtD
Alprazolam—Vision blurred—Prednisone—ankylosing spondylitis	0.000515	0.00165	CcSEcCtD
Alprazolam—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000514	0.00165	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000514	0.00165	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000513	0.00165	CcSEcCtD
Alprazolam—Oedema—Betamethasone—ankylosing spondylitis	0.000512	0.00164	CcSEcCtD
Alprazolam—Oedema—Dexamethasone—ankylosing spondylitis	0.000512	0.00164	CcSEcCtD
Alprazolam—Insomnia—Triamcinolone—ankylosing spondylitis	0.00051	0.00164	CcSEcCtD
Alprazolam—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000509	0.00163	CcSEcCtD
Alprazolam—Infection—Dexamethasone—ankylosing spondylitis	0.000509	0.00163	CcSEcCtD
Alprazolam—Infection—Betamethasone—ankylosing spondylitis	0.000509	0.00163	CcSEcCtD
Alprazolam—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000507	0.00163	CcSEcCtD
Alprazolam—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000507	0.00162	CcSEcCtD
Alprazolam—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000506	0.00162	CcSEcCtD
Alprazolam—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000505	0.00162	CcSEcCtD
Alprazolam—Shock—Betamethasone—ankylosing spondylitis	0.000504	0.00162	CcSEcCtD
Alprazolam—Shock—Dexamethasone—ankylosing spondylitis	0.000504	0.00162	CcSEcCtD
Alprazolam—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000503	0.00161	CcSEcCtD
Alprazolam—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000502	0.00161	CcSEcCtD
Alprazolam—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000502	0.00161	CcSEcCtD
Alprazolam—Agitation—Prednisone—ankylosing spondylitis	0.000502	0.00161	CcSEcCtD
Alprazolam—Tachycardia—Dexamethasone—ankylosing spondylitis	0.0005	0.0016	CcSEcCtD
Alprazolam—Tachycardia—Betamethasone—ankylosing spondylitis	0.0005	0.0016	CcSEcCtD
Alprazolam—Angioedema—Prednisone—ankylosing spondylitis	0.000499	0.0016	CcSEcCtD
Alprazolam—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000497	0.00159	CcSEcCtD
Alprazolam—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000496	0.00159	CcSEcCtD
Alprazolam—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000495	0.00159	CcSEcCtD
Alprazolam—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000495	0.00159	CcSEcCtD
Alprazolam—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000495	0.00159	CcSEcCtD
Alprazolam—Malaise—Prednisone—ankylosing spondylitis	0.000493	0.00158	CcSEcCtD
Alprazolam—Vertigo—Prednisone—ankylosing spondylitis	0.000491	0.00157	CcSEcCtD
Alprazolam—Eye disorder—Methotrexate—ankylosing spondylitis	0.00049	0.00157	CcSEcCtD
Alprazolam—Syncope—Prednisone—ankylosing spondylitis	0.00049	0.00157	CcSEcCtD
Alprazolam—Tinnitus—Methotrexate—ankylosing spondylitis	0.000489	0.00157	CcSEcCtD
Alprazolam—Anorexia—Dexamethasone—ankylosing spondylitis	0.000488	0.00157	CcSEcCtD
Alprazolam—Anorexia—Betamethasone—ankylosing spondylitis	0.000488	0.00157	CcSEcCtD
Alprazolam—Urticaria—Prednisolone—ankylosing spondylitis	0.000487	0.00156	CcSEcCtD
Alprazolam—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000487	0.00156	CcSEcCtD
Alprazolam—Fatigue—Triamcinolone—ankylosing spondylitis	0.000486	0.00156	CcSEcCtD
Alprazolam—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000485	0.00156	CcSEcCtD
Alprazolam—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00048	0.00154	CcSEcCtD
Alprazolam—Hypotension—Dexamethasone—ankylosing spondylitis	0.000478	0.00153	CcSEcCtD
Alprazolam—Hypotension—Betamethasone—ankylosing spondylitis	0.000478	0.00153	CcSEcCtD
Alprazolam—Angiopathy—Methotrexate—ankylosing spondylitis	0.000476	0.00153	CcSEcCtD
Alprazolam—Convulsion—Prednisone—ankylosing spondylitis	0.000473	0.00152	CcSEcCtD
Alprazolam—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000473	0.00152	CcSEcCtD
Alprazolam—Chills—Methotrexate—ankylosing spondylitis	0.000471	0.00151	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000466	0.0015	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000466	0.0015	CcSEcCtD
Alprazolam—Arthralgia—Prednisone—ankylosing spondylitis	0.000465	0.00149	CcSEcCtD
Alprazolam—Myalgia—Prednisone—ankylosing spondylitis	0.000465	0.00149	CcSEcCtD
Alprazolam—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000465	0.00149	CcSEcCtD
Alprazolam—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000464	0.00149	CcSEcCtD
Alprazolam—Anxiety—Prednisone—ankylosing spondylitis	0.000463	0.00149	CcSEcCtD
Alprazolam—Insomnia—Dexamethasone—ankylosing spondylitis	0.000463	0.00149	CcSEcCtD
Alprazolam—Insomnia—Betamethasone—ankylosing spondylitis	0.000463	0.00149	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000462	0.00148	CcSEcCtD
Alprazolam—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00046	0.00148	CcSEcCtD
Alprazolam—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00046	0.00147	CcSEcCtD
Alprazolam—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00046	0.00147	CcSEcCtD
Alprazolam—Discomfort—Prednisone—ankylosing spondylitis	0.000459	0.00147	CcSEcCtD
Alprazolam—Mental disorder—Methotrexate—ankylosing spondylitis	0.000459	0.00147	CcSEcCtD
Alprazolam—Malnutrition—Methotrexate—ankylosing spondylitis	0.000456	0.00146	CcSEcCtD
Alprazolam—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000452	0.00145	CcSEcCtD
Alprazolam—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000451	0.00145	CcSEcCtD
Alprazolam—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000451	0.00145	CcSEcCtD
Alprazolam—Urticaria—Triamcinolone—ankylosing spondylitis	0.000448	0.00144	CcSEcCtD
Alprazolam—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000447	0.00143	CcSEcCtD
Alprazolam—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000446	0.00143	CcSEcCtD
Alprazolam—Oedema—Prednisone—ankylosing spondylitis	0.000446	0.00143	CcSEcCtD
Alprazolam—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000445	0.00143	CcSEcCtD
Alprazolam—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000445	0.00143	CcSEcCtD
Alprazolam—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000445	0.00143	CcSEcCtD
Alprazolam—Infection—Prednisone—ankylosing spondylitis	0.000443	0.00142	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000442	0.00142	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000442	0.00142	CcSEcCtD
Alprazolam—Back pain—Methotrexate—ankylosing spondylitis	0.000442	0.00142	CcSEcCtD
Alprazolam—Fatigue—Dexamethasone—ankylosing spondylitis	0.000441	0.00142	CcSEcCtD
Alprazolam—Fatigue—Betamethasone—ankylosing spondylitis	0.000441	0.00142	CcSEcCtD
Alprazolam—Shock—Prednisone—ankylosing spondylitis	0.000439	0.00141	CcSEcCtD
Alprazolam—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000437	0.0014	CcSEcCtD
Alprazolam—Tachycardia—Prednisone—ankylosing spondylitis	0.000435	0.0014	CcSEcCtD
Alprazolam—Skin disorder—Prednisone—ankylosing spondylitis	0.000433	0.00139	CcSEcCtD
Alprazolam—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000431	0.00138	CcSEcCtD
Alprazolam—Vision blurred—Methotrexate—ankylosing spondylitis	0.00043	0.00138	CcSEcCtD
Alprazolam—Anorexia—Prednisone—ankylosing spondylitis	0.000425	0.00136	CcSEcCtD
Alprazolam—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000424	0.00136	CcSEcCtD
Alprazolam—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000422	0.00135	CcSEcCtD
Alprazolam—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000422	0.00135	CcSEcCtD
Alprazolam—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000419	0.00134	CcSEcCtD
Alprazolam—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000419	0.00134	CcSEcCtD
Alprazolam—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000416	0.00133	CcSEcCtD
Alprazolam—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000415	0.00133	CcSEcCtD
Alprazolam—Malaise—Methotrexate—ankylosing spondylitis	0.000412	0.00132	CcSEcCtD
Alprazolam—Vertigo—Methotrexate—ankylosing spondylitis	0.00041	0.00132	CcSEcCtD
Alprazolam—Urticaria—Dexamethasone—ankylosing spondylitis	0.000407	0.0013	CcSEcCtD
Alprazolam—Urticaria—Betamethasone—ankylosing spondylitis	0.000407	0.0013	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000406	0.0013	CcSEcCtD
Alprazolam—Dizziness—Prednisolone—ankylosing spondylitis	0.000406	0.0013	CcSEcCtD
Alprazolam—Asthenia—Triamcinolone—ankylosing spondylitis	0.000405	0.0013	CcSEcCtD
Alprazolam—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000405	0.0013	CcSEcCtD
Alprazolam—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000405	0.0013	CcSEcCtD
Alprazolam—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000405	0.0013	CcSEcCtD
Alprazolam—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000405	0.0013	CcSEcCtD
Alprazolam—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000404	0.0013	CcSEcCtD
Alprazolam—Insomnia—Prednisone—ankylosing spondylitis	0.000403	0.00129	CcSEcCtD
Alprazolam—Paraesthesia—Prednisone—ankylosing spondylitis	0.0004	0.00128	CcSEcCtD
Alprazolam—Pruritus—Triamcinolone—ankylosing spondylitis	0.000399	0.00128	CcSEcCtD
Alprazolam—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000398	0.00128	CcSEcCtD
Alprazolam—Convulsion—Methotrexate—ankylosing spondylitis	0.000395	0.00127	CcSEcCtD
Alprazolam—Dyspepsia—Prednisone—ankylosing spondylitis	0.000392	0.00126	CcSEcCtD
Alprazolam—Myalgia—Methotrexate—ankylosing spondylitis	0.000389	0.00125	CcSEcCtD
Alprazolam—Chest pain—Methotrexate—ankylosing spondylitis	0.000389	0.00125	CcSEcCtD
Alprazolam—Arthralgia—Methotrexate—ankylosing spondylitis	0.000389	0.00125	CcSEcCtD
Alprazolam—Decreased appetite—Prednisone—ankylosing spondylitis	0.000388	0.00124	CcSEcCtD
Alprazolam—Rash—Prednisolone—ankylosing spondylitis	0.000387	0.00124	CcSEcCtD
Alprazolam—Dermatitis—Prednisolone—ankylosing spondylitis	0.000386	0.00124	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000386	0.00124	CcSEcCtD
Alprazolam—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000385	0.00124	CcSEcCtD
Alprazolam—Fatigue—Prednisone—ankylosing spondylitis	0.000384	0.00123	CcSEcCtD
Alprazolam—Headache—Prednisolone—ankylosing spondylitis	0.000384	0.00123	CcSEcCtD
Alprazolam—Discomfort—Methotrexate—ankylosing spondylitis	0.000384	0.00123	CcSEcCtD
Alprazolam—Constipation—Prednisone—ankylosing spondylitis	0.000381	0.00122	CcSEcCtD
Alprazolam—Confusional state—Methotrexate—ankylosing spondylitis	0.000376	0.0012	CcSEcCtD
Alprazolam—Dizziness—Triamcinolone—ankylosing spondylitis	0.000373	0.0012	CcSEcCtD
Alprazolam—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000372	0.00119	CcSEcCtD
Alprazolam—Infection—Methotrexate—ankylosing spondylitis	0.00037	0.00119	CcSEcCtD
Alprazolam—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000367	0.00118	CcSEcCtD
Alprazolam—Asthenia—Betamethasone—ankylosing spondylitis	0.000367	0.00118	CcSEcCtD
Alprazolam—Asthenia—Dexamethasone—ankylosing spondylitis	0.000367	0.00118	CcSEcCtD
Alprazolam—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000365	0.00117	CcSEcCtD
Alprazolam—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000365	0.00117	CcSEcCtD
Alprazolam—Nausea—Prednisolone—ankylosing spondylitis	0.000364	0.00117	CcSEcCtD
Alprazolam—Pruritus—Dexamethasone—ankylosing spondylitis	0.000362	0.00116	CcSEcCtD
Alprazolam—Pruritus—Betamethasone—ankylosing spondylitis	0.000362	0.00116	CcSEcCtD
Alprazolam—Skin disorder—Methotrexate—ankylosing spondylitis	0.000362	0.00116	CcSEcCtD
Alprazolam—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00036	0.00116	CcSEcCtD
Alprazolam—Vomiting—Triamcinolone—ankylosing spondylitis	0.000359	0.00115	CcSEcCtD
Alprazolam—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000358	0.00115	CcSEcCtD
Alprazolam—Rash—Triamcinolone—ankylosing spondylitis	0.000356	0.00114	CcSEcCtD
Alprazolam—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000355	0.00114	CcSEcCtD
Alprazolam—Anorexia—Methotrexate—ankylosing spondylitis	0.000355	0.00114	CcSEcCtD
Alprazolam—Rash—Methylprednisolone—ankylosing spondylitis	0.000355	0.00114	CcSEcCtD
Alprazolam—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000355	0.00114	CcSEcCtD
Alprazolam—Urticaria—Prednisone—ankylosing spondylitis	0.000354	0.00114	CcSEcCtD
Alprazolam—Headache—Triamcinolone—ankylosing spondylitis	0.000353	0.00113	CcSEcCtD
Alprazolam—Headache—Methylprednisolone—ankylosing spondylitis	0.000353	0.00113	CcSEcCtD
Alprazolam—Body temperature increased—Prednisone—ankylosing spondylitis	0.000352	0.00113	CcSEcCtD
Alprazolam—Abdominal pain—Prednisone—ankylosing spondylitis	0.000352	0.00113	CcSEcCtD
Alprazolam—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00035	0.00112	CcSEcCtD
Alprazolam—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00035	0.00112	CcSEcCtD
Alprazolam—Hypotension—Methotrexate—ankylosing spondylitis	0.000348	0.00112	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000339	0.00109	CcSEcCtD
Alprazolam—Dizziness—Dexamethasone—ankylosing spondylitis	0.000338	0.00109	CcSEcCtD
Alprazolam—Dizziness—Betamethasone—ankylosing spondylitis	0.000338	0.00109	CcSEcCtD
Alprazolam—Insomnia—Methotrexate—ankylosing spondylitis	0.000337	0.00108	CcSEcCtD
Alprazolam—Nausea—Triamcinolone—ankylosing spondylitis	0.000335	0.00107	CcSEcCtD
Alprazolam—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000335	0.00107	CcSEcCtD
Alprazolam—Nausea—Methylprednisolone—ankylosing spondylitis	0.000334	0.00107	CcSEcCtD
Alprazolam—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000332	0.00107	CcSEcCtD
Alprazolam—Somnolence—Methotrexate—ankylosing spondylitis	0.000331	0.00106	CcSEcCtD
Alprazolam—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000328	0.00105	CcSEcCtD
Alprazolam—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000328	0.00105	CcSEcCtD
Alprazolam—Vomiting—Dexamethasone—ankylosing spondylitis	0.000325	0.00104	CcSEcCtD
Alprazolam—Vomiting—Betamethasone—ankylosing spondylitis	0.000325	0.00104	CcSEcCtD
Alprazolam—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000324	0.00104	CcSEcCtD
Alprazolam—Rash—Dexamethasone—ankylosing spondylitis	0.000323	0.00104	CcSEcCtD
Alprazolam—Rash—Betamethasone—ankylosing spondylitis	0.000323	0.00104	CcSEcCtD
Alprazolam—Dermatitis—Betamethasone—ankylosing spondylitis	0.000322	0.00103	CcSEcCtD
Alprazolam—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000322	0.00103	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000322	0.00103	CcSEcCtD
Alprazolam—Fatigue—Methotrexate—ankylosing spondylitis	0.000321	0.00103	CcSEcCtD
Alprazolam—Headache—Dexamethasone—ankylosing spondylitis	0.000321	0.00103	CcSEcCtD
Alprazolam—Headache—Betamethasone—ankylosing spondylitis	0.000321	0.00103	CcSEcCtD
Alprazolam—Asthenia—Prednisone—ankylosing spondylitis	0.00032	0.00103	CcSEcCtD
Alprazolam—Pruritus—Prednisone—ankylosing spondylitis	0.000315	0.00101	CcSEcCtD
Alprazolam—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000307	0.000985	CcSEcCtD
Alprazolam—Diarrhoea—Prednisone—ankylosing spondylitis	0.000305	0.000978	CcSEcCtD
Alprazolam—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000305	0.000977	CcSEcCtD
Alprazolam—Nausea—Dexamethasone—ankylosing spondylitis	0.000304	0.000975	CcSEcCtD
Alprazolam—Nausea—Betamethasone—ankylosing spondylitis	0.000304	0.000975	CcSEcCtD
Alprazolam—Urticaria—Methotrexate—ankylosing spondylitis	0.000296	0.000949	CcSEcCtD
Alprazolam—Dizziness—Prednisone—ankylosing spondylitis	0.000295	0.000946	CcSEcCtD
Alprazolam—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000295	0.000945	CcSEcCtD
Alprazolam—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000295	0.000945	CcSEcCtD
Alprazolam—Vomiting—Prednisone—ankylosing spondylitis	0.000283	0.000909	CcSEcCtD
Alprazolam—Rash—Prednisone—ankylosing spondylitis	0.000281	0.000902	CcSEcCtD
Alprazolam—Dermatitis—Prednisone—ankylosing spondylitis	0.000281	0.000901	CcSEcCtD
Alprazolam—Headache—Prednisone—ankylosing spondylitis	0.000279	0.000896	CcSEcCtD
Alprazolam—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000274	0.00088	CcSEcCtD
Alprazolam—Asthenia—Methotrexate—ankylosing spondylitis	0.000267	0.000857	CcSEcCtD
Alprazolam—Nausea—Prednisone—ankylosing spondylitis	0.000265	0.000849	CcSEcCtD
Alprazolam—Pruritus—Methotrexate—ankylosing spondylitis	0.000264	0.000845	CcSEcCtD
Alprazolam—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000255	0.000818	CcSEcCtD
Alprazolam—Dizziness—Methotrexate—ankylosing spondylitis	0.000246	0.00079	CcSEcCtD
Alprazolam—Vomiting—Methotrexate—ankylosing spondylitis	0.000237	0.00076	CcSEcCtD
Alprazolam—Rash—Methotrexate—ankylosing spondylitis	0.000235	0.000753	CcSEcCtD
Alprazolam—Dermatitis—Methotrexate—ankylosing spondylitis	0.000235	0.000753	CcSEcCtD
Alprazolam—Headache—Methotrexate—ankylosing spondylitis	0.000233	0.000749	CcSEcCtD
Alprazolam—Nausea—Methotrexate—ankylosing spondylitis	0.000221	0.00071	CcSEcCtD
